Why Is BAUSCH HEALTH COS IN (BHC) Stock Up Today?

Bausch Health Companies Inc (BHC) shares surged 23.70% to close at $8.56. The primary driver was a strong third-quarter 2026 earnings report that exceeded expectations on both earnings per share and revenue, alongside a significant increase in full-year guidance.

What Happened

The company reported non-GAAP earnings per share of $1.77, which beat estimates by $0.53. Revenue for the quarter reached $2.94 billion, surpassing forecasts by $190 million. Management highlighted an adjusted EBITDA milestone above $1 billion and noted a debt reduction of $521 million. Bausch Health raised its 2026 revenue guidance to a range of $5.525 billion to $5.625 billion. The company also authorized a $50 million share repurchase program to offset equity compensation dilution and announced the full redemption of its 8.500% senior notes due 2027. RBC raised its price target on the stock to $10 from $9 following the release.

What The Data Shows

The stock opened at $7.45, representing a 7.7% gap from the prior close of $6.92. Trading reached a session high of $8.58 at 9:40 AM ET and a low of $7.28 at 7:35 AM ET. Volume stood at 2.2 million shares, which is 0.7 times the three-month daily average. The move pushed the stock to four fresh 52-week highs on October 29, 2026, despite the 52-week range previously ending at $8.00. Over the last eight sessions, the stock had already moved up 9.5% from $6.32 to $6.92. Fundamentals show a market cap of $2.4 billion with a beta of 0.37. The company remains unprofitable on a trailing twelve-month basis with an EPS of -$2.95 and a net margin of -10.1%, though revenue grew 10.1% over the same period. Recent insider activity includes one sale totaling $259,000 by Aimee J. Lenar on August 19, 2026.

What To Watch

Investors will monitor the company's ability to navigate flagged fourth-quarter headwinds for Xifaxan while maintaining its raised guidance.